PROJECT I - NEUROHUMORAL AND RENAL MECHANISMS OF HYPERTENSION PROJECT SUMMARY/ABSTRACT Although impaired renal-pressure natriuresis occurs in all forms of chronic hypertension studied thus far, neurohumoral mechanisms often mediate abnormal kidney function and increased blood pressure (BP). Therefore, our research is directed toward understanding neurohumoral mechanisms that alter kidney function in hypertension caused by excess weight gain which accounts for 65-75% of human essential hypertension. We previously demonstrated that increased sympathetic nervous system (SNS) activity plays a major role in the pathophysiology of obesity-hypertension mainly by stimulation of renal sympathetic nerve activity (RSNA). We also found that leptin, an adipocyte derived hormone, contributes to SNS activation and increased BP in obesity by stimulating CNS pro-opiomelanocortin (POMC) neurons and ultimately by activation of melanocortin 4 receptors (MC4R). Our studies also indicate that the CNS POMC-MC4R pathway is a key means by which leptin regulates glucose homeostasis. Moreover, POMC activation can regulate BP and glucose independent of its effects to reduce appetite. The complex CNS circuits that mediate this differential control of cardiovascular and metabolic functions are still poorly understood. In addition, we found that the POMC-MC4R pathway may be important for BP regulation independent of leptin. The central hypothesis of this proposal is that POMC-MC4R activation in distinct areas of the hypothalamus, brainstem and spinal cord can differentially and independently regulate BP, RSNA, and metabolic functions, including appetite and energy expenditure. The proposed studies will determine which specific brain regions are most important in mediating the chronic effects of POMC-MC4R activation on RSNA, baroreflexes and BP regulation, food intake and energy expenditure, as well as the cardiometabolic responses to leptin. We will also determine the role of suppressor of cytokine signaling-3 (SOCS3) and protein tyrosine phosphatase 1B (PTP1B), in modulating leptin's actions on POMC and other neurons of the forebrain, brainstem and spinal cord in regulating cardiometabolic functions. These studies will employ unique, genetically engineered mouse models that permit us to delete or """"""""rescue"""""""" MC4R, SOCS3, or PTP1B in specific neuronal populations of the hypothalamus, brainstem and spinal cord. Sophisticated physiological techniques that provide computerized chronic monitoring of cardiovascular, renal and metabolic functions, coupled with novel animal models, will permit us to unravel the specific CNS circuits by which the POMC-MC4R pathway differentially controls metabolic and cardiovascular functions, and the role of SOCS3 and PTP1B in modulating this system in obesity.

Public Health Relevance

PROJECT I - NEUROHUMORAL AND RENAL MECHANISMS OF HYPERTENSION PROJECT NARRATIVE Excess weight gain and obesity account for 65-75% of human essential hypertension and are major risk factors for cardiovascular, kidney and metabolic diseases. Our previous studies indicate that activation of the sympathetic nervous system (SNS) plays a major role in obesity-induced hypertension and that this may be closely linked to a hormone called leptin which is secreted by fat cells and acts on specific brain cells called proopiomelanocortin (POMC) neurons. These neurons release a protein that activates specific receptors in the brain called melanocortin 4 receptors (MC4R) leading to SNS stimulation and hypertension. However, the neuronal circuits involved in MC4R-mediated SNS activation are unclear and are the primary focus of the proposed experiments. Understanding the physiology of this pathway and how it is altered in obesity offers promise for treatment of the cardiovascular and metabolic disorders associated with obesity

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Program Project Review Committee (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Mississippi Medical Center
United States
Zip Code
Faulkner, Jessica L; Plenty, Nicole L; Wallace, Kedra et al. (2018) Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia. Prostaglandins Other Lipid Mediat 134:108-113
Spann, Redin A; Lawson, William J; Bidwell 3rd, Gene L et al. (2018) Rodent vertical sleeve gastrectomy alters maternal immune health and fetoplacental development. Clin Sci (Lond) 132:295-312
Lindsey, Merry L; Jung, Mira; Hall, Michael E et al. (2018) Proteomic analysis of the cardiac extracellular matrix: clinical research applications. Expert Rev Proteomics 15:105-112
Mouton, Alan J; Rivera Gonzalez, Osvaldo J; Kaminski, Amanda R et al. (2018) Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction. Pharmacol Res 137:252-258
Cates, Courtney; Rousselle, Thomas; Wang, Jinli et al. (2018) Activated protein C protects against pressure overload-induced hypertrophy through AMPK signaling. Biochem Biophys Res Commun 495:2584-2594
do Carmo, Jussara M; da Silva, Alexandre A; Moak, Sydney P et al. (2018) Increased sleep time and reduced energy expenditure contribute to obesity after ovariectomy and a high fat diet. Life Sci 212:119-128
Taylor, Erin B; Barati, Michelle T; Powell, David W et al. (2018) Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease. Hypertension 71:719-728
Lindsey, Merry L (2018) Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling. Nat Rev Cardiol 15:471-479
Wang, Lin; Quan, Nanhu; Sun, Wanqing et al. (2018) Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury. Cardiovasc Res 114:805-821
do Carmo, Jussara M; da Silva, Alexandre A; Freeman, John Nathan et al. (2018) Neuronal Suppressor of Cytokine Signaling 3: Role in Modulating Chronic Metabolic and Cardiovascular Effects of Leptin. Hypertension 71:1248-1257

Showing the most recent 10 out of 767 publications